Lista de obras -

Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli

artículo científico publicado en 2005

Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.

artículo científico publicado en 2006

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.

artículo científico publicado en 2006

Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli

artículo científico publicado en 2005

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin

artículo científico publicado en 2007

Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study

artículo científico publicado en 2006

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection

artículo científico publicado en 2010

Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study

artículo científico publicado en 2012

Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia

artículo científico publicado en 2008

Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.

artículo científico publicado en 2013

Effect of the novel influenza A (H1N1) virus in the human immune system

artículo científico publicado en 2009

Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis

artículo científico publicado en 2008

Evidence for the Participation of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in the Systemic Inflammatory Response Syndrome After Multiple Trauma

artículo científico publicado en 2008

Genetic polymorphisms within tumor necrosis factor gene promoter region: A role for susceptibility to ventilator-associated pneumonia

article

OLEUROPEIN

article

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

scientific article published on 12 May 2020

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease

artículo científico publicado en 2006

Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection

artículo científico publicado en 2012

Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis

artículo científico publicado en 2006

Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis

artículo científico publicado en 2011

Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study

scientific article published on 05 November 2019

Lista de obras de

Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli

Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.

Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin

Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection

Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study

Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia

Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.

Effect of the novel influenza A (H1N1) virus in the human immune system

Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis

Evidence for the Participation of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in the Systemic Inflammatory Response Syndrome After Multiple Trauma

Genetic polymorphisms within tumor necrosis factor gene promoter region: A role for susceptibility to ventilator-associated pneumonia

OLEUROPEIN

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease

Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection

Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis

Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis

Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study